| David Isaac Bloom, MD | |
|
5350 W Atlantic Ave, Ste 100, Delray Beach, FL 33484-8112 | |
| (561) 496-5677 | |
| (561) 496-5824 |
| Full Name | David Isaac Bloom |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 5350 W Atlantic Ave, Delray Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104874759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | ME0051152 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Isaac Bloom, MD 5350 W Atlantic Ave, Ste 100, Delray Beach, FL 33484-8112 Ph: (561) 496-5677 | David Isaac Bloom, MD 5350 W Atlantic Ave, Ste 100, Delray Beach, FL 33484-8112 Ph: (561) 496-5677 |
News Archive
The new recipients of the most important prize for early-career researchers in Germany have been announced. The selection committee, appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF), has chosen three young men and three young women to receive the Heinz Maier-Leibnitz Prize 2012.
Canadian federal officials have confirmed that farmed salmon with trace amounts of a banned chemical have recently been found on store shelves.
Popular media mirror Western culture's fixation with being thin. According to a new study in the Journal of Consumer Research, even subtle reminders of idealized bodies can encourage overweight consumers to overspend.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
Human Genome Sciences, Inc. today announced that Novartis has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN™) for the treatment of chronic hepatitis C. In November 2009, HGS submitted a Biologics License Application (BLA) for ZALBIN to the FDA in the United States.
› Verified 9 days ago
Dr. Chelsea Chapkin Albanese, D.O. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 15340 S Jog Rd Ste 200, Delray Beach, FL 33446 Phone: 561-496-7200 | |
Dr. Alvin Gordon Beyerlein Jr., MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 15300 S Jog Rd Ste 205, Delray Beach, FL 33446 Phone: 561-493-7200 Fax: 561-496-7989 | |
Dr. Ahmet H Lavkan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4662 Hammock Cir, Delray Beach, FL 33445 Phone: 561-254-6464 | |
Marlon Amos Labi, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 13593 Barcelona Lake Cir, Delray Beach, FL 33446 Phone: 954-849-4953 | |
John Receveur, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2932 Sw 22nd Cir Apt B, Delray Beach, FL 33445 Phone: 302-507-4975 | |
Rodolfo Reyes, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N Congress Ave Ste 403, Delray Beach, FL 33445 Phone: 561-272-1618 Fax: 561-272-2880 | |
Marie Rubby Roger, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 13455 S Military Trl Ste A, Delray Beach, FL 33484 Phone: 561-288-6153 Fax: 561-288-6087 |